Evidence map›Paper›PMID 20053740›Full record

ArticleJournal of virology2010

Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection.

Michael L Freeman, Kathleen G Lanzer, Tres Cookenham, Bjoern Peters, John Sidney, Ting-Ting Wu, Ren Sun, David L Woodland, Alessandro Sette, Marcia A Blackman

Abstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?Frontiers in cellular and infection microbiology · 2018
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Michael L FreemanTrudeau Institute, Saranac Lake, New York 12983, USA.
Kathleen G Lanzer
Tres Cookenham
Bjoern Peters
John Sidney
Ting-Ting Wu
Ren Sun
David L Woodland
Alessandro Sette
Marcia A Blackman
Trudeau Institute · USLa Jolla Institute for Immunology · USUniversity of California, Los Angeles · US

Funding

Reactivation of Kaposi's Sarcoma-Associated HerpesvirusR01CA091791 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2001 to 2017
$4.4M
T CELL IMMUNITY TO MHV 68, A MURINE GAMMA HERPEVIRUSR01AI042927 · NIAID · TRUDEAU INSTITUTE, INC. · PI BLACKMAN, MARCIA A · 1998 to 2008
$2.5M
Research Training in Immunology and Infectious DiseasesT32AI049823 · NIAID · TRUDEAU INSTITUTE, INC. · PI COOPER, ANDREA M · 2001 to 2015
$2.1M
Role of Interleukin-6 in Gammaherpesvirus replicationR01DE015752 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2003 to 2007
$1.6M
Viral Lysis of Kaposi's Sarcoma Tumor CellsR01DE014153 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2001 to 2004
$1.1M
Immunogenicity and efficacy of genetically engineered gamma-herpesvirus vaccinesRC2CA148250 · NCI · TRUDEAU INSTITUTE, INC. · PI BLACKMAN, MARCIA A, SUN, REN · 2009 to 2010
$1000k
Genetic Analysis of Interactions Between Oral Innate Immunity and a HerpesvirusR21DE018337 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WU, TING-TING · 2007 to 2008
$421k
CD* T cell responses to gamma-herpesviral infectionF32AI084327 · NIAID · TRUDEAU INSTITUTE, INC. · PI FREEMAN, MICHAEL L · 2009 to 2010
$98k
NCI NIH HHS CA148250NCI NIH HHS CA91791NCI NIH HHS R01 CA091791NCI NIH HHS RC2 CA148250NIAID NIH HHS AI42927NIAID NIH HHS F32 AI084327NIAID NIH HHS N01-AI400023CNIAID NIH HHS N01-AI400024CNIAID NIH HHS R01 AI042927NIAID NIH HHS T32 AI049823NIAID NIH HHS T32 AI49823NIDCR NIH HHS DE14153NIDCR NIH HHS DE15752NIDCR NIH HHS DE18337NIDCR NIH HHS R01 DE014153NIDCR NIH HHS R01 DE015752NIDCR NIH HHS R21 DE018337
6 · The paper itself

Abstract

Murine gammaherpesvirus 68 (gammaHV68) provides an important experimental model for understanding mechanisms of immune control of the latent human gammaherpesviruses. Antiviral CD8 T cells play a key role throughout three separate phases of the infection: clearance of lytic virus, control of the latency amplification stage, and prevention of reactivation of latently infected cells. Previous analyses have shown that T-cell responses to two well-characterized epitopes derived from ORF6 and ORF61 progress with distinct kinetics. ORF6(487)-specific cells predominate early in infection and then decline rapidly, whereas ORF61(524)-specific cells continue to expand through early latency, due to sustained epitope expression. However, the paucity of identified epitopes to this virus has limited our understanding of the overall complexities of CD8 T-cell immune control throughout infection. Here we screened 1,383 predicted H-2(b)-restricted peptides and identified 33 responses, of which 21 have not previously been reported. Kinetic analysis revealed a spectrum of T-cell responses based on the rapidity of their decline after the peak acute response that generally corresponded to the expression patterns of the two previously characterized epitopes. The slowly declining responses that were maintained during latency amplification proliferated more rapidly and underwent maturation of functional avidity over time. Furthermore, the kinetics of decline was accelerated following infection with a latency-null mutant virus. Overall, the data show that gammaHV68 infection elicits a highly heterogeneous CD8 T-cell response that segregates into two distinctive kinetic patterns controlled by differential epitope expression during the lytic and latency amplification stages of infection.

Indexed as

Amino Acid SequenceAnimalsAntigens, ViralCD8-Positive T-LymphocytesEpitopes, T-LymphocyteFemaleHerpesviridae InfectionsHumansLymphocyte ActivationMiceMice, Inbred C57BLMolecular Sequence DataOpen Reading FramesPeptidesRhadinovirusT-Lymphocyte SubsetsAntigens, ViralEpitopes, T-LymphocytePeptides

Identifiers

PMID20053740
PMCPMC2826075
OpenAlexW1977728770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.